PTC Therapeutics, Inc.
PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program
PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that its Board of Directors has authorized a share repurchase program under which PTC may…